These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 15833846)

  • 1. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
    Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
    Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
    Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
    Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
    Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B
    Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential gene expression during apoptosis induced by a serum factor: role of mitochondrial F0-F1 ATP synthase complex.
    Singh S; Khar A
    Apoptosis; 2005 Dec; 10(6):1469-82. PubMed ID: 16215688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
    McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
    Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
    Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
    Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle perturbation and acquired 5-fluorouracil chemoresistance.
    Guo X; Goessl E; Jin G; Collie-Duguid ES; Cassidy J; Wang W; O'Brien V
    Anticancer Res; 2008; 28(1A):9-14. PubMed ID: 18383818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
    Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
    Johnston PG; Drake JC; Trepel J; Allegra CJ
    Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
    Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
    Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
    Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N
    Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of 5-fluorouracil sensitivity by an rTS signaling mimic in H630 colon cancer cells.
    Dolnick R; Wu Q; Angelino NJ; Stephanie LV; Chow KC; Sufrin JR; Dolnick BJ
    Cancer Res; 2005 Jul; 65(13):5917-24. PubMed ID: 15994970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.